Molecular biology of neurodegenerative diseases : visions for the future
Author(s)
Bibliographic Information
Molecular biology of neurodegenerative diseases : visions for the future
(Progress in molecular biology and translational science, v. 168)
Academic Press, an imprint of Elsevier, 2019
- pt. A
Available at 4 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Volume 168 in the Progress in Molecular Biology and Translational Science series, provides the most topical, informative and exciting monographs available on a wide variety of research topics. The series includes in-depth knowledge on the molecular biological aspects of organismal physiology, with this release including chapters on Alzheimer's disease, Prion-like propagation of alpha-synuclein, What - if anything - can we learn about neurodegenerative diseases from yeast?, Mitochondrial rejuvenation and replacement as a novel strategy for treatment of age-related neurodegenerative diseases, Propagation and removal of cerebral amyloid angiopathy, and much more.
Table of Contents
Section I: TARGETTING AD
1. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings
Kaj Blennow and Henrik Zetterberg
2. Tracking down a missing trigger for Alzheimer's disease by mass spectrometric imaging based on brain network analysis
Minako Hoshi
3. Using mirror-image peptides to enhance robustness and reproducibility in studying the amyloid ss-protein
Ariel J. Kuhn and Jevgenij A. Raskatov
Section II: ETIOLOGY OF AD
4. In search of pathogenic amyloid ss-peptide in familial Alzheimer's disease
Michael S. Wolfe
5. Biology of splicing in Alzheimer's disease research
Kenichi Nagata, Takashi Saito, Takaomi C. Saido and Takashi Morihara
6. Acquired cerebral amyloid angiopathy: An emerging concept
Masahito Yamada, Tsuyoshi Hamaguchi and Kenji Sakai
Section III: NEUROIMMUNOLOGY OF AD
7. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Goran Simic, Ena Spanic, Lea Langer Horvat and Patrick R. Hof
8. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease
Susan Westfall, Umar Iqbal, Maria Sebastian and Giulio Maria Pasinetti
9. Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges?
Stefan Prokop, Virginia M.Y. Lee and John Q. Trojanowski
Section IV: AD THERAPY
10. Alzheimer's therapy development: A few points to consider
Einar M. Sigurdsson
11. The next steps in curing Alzheimer's disease
Fred W. van Leeuwen
12. Future horizons in Alzheimer's disease research
Thomas Wisniewski and Eleanor Drummond
13. Why delay in effective treatment for Alzheimer's disease and related conditions
Khalid Iqbal, Fei Liu, ChengXin Gong, Chunling Dai and Wen Hu
14. Restoring synaptic function through multimodal therapeutics
Raul Loera-Valencia, Muhammad-Al-Mustafa Ismail, Per Nilsson and Bengt Winblad
15. Disease-modifying therapy for proteinopathies: Can the exception become the rule?
Gal Bitan
16. Combination therapy for Alzheimer's disease and related dementias
Martin M. Bednar
Section V: ALPHA-SYNUCLEINOPATHIES
17. Can infections trigger alpha-synucleinopathies?
Christopher T. Tulisiak, Gabriela Mercado, Wouter Peelaerts, Lena Brundin and Patrik Brundin
18. Prion-like propagation of a-synuclein in neurodegenerative diseases
Airi Tarutani and Masato Hasegawa
Section VI: MODEL SYSTEMS
19. Yeast models of neurodegenerative diseases
Mick F. Tuite
by "Nielsen BookData"